ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+9.48%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$153M
AUM Growth
+$153M
(+37%)
Cap. Flow
+$42.2M
Cap. Flow
% of AUM
27.59%
Top 10 Holdings %
Top 10 Hldgs %
56.26%
Holding
71
New
20
Increased
16
Reduced
11
Closed
16
Top Buys
| 1 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$11.5M |
| 2 |
Veracyte
VCYT
|
$8.89M |
| 3 |
SPNC
Spectranetics Corp
SPNC
|
$5.75M |
| 4 |
AGEN
Agenus
AGEN
|
$3.83M |
| 5 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$3.74M |
Top Sells
| 1 |
CEMP
Cempra, Inc.
CEMP
|
$5.34M |
| 2 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$3.74M |
| 3 |
Insmed
INSM
|
$3.12M |
| 4 |
Amicus Therapeutics
FOLD
|
$2.68M |
| 5 |
LeMaitre Vascular
LMAT
|
$2.61M |
Sector Composition
| 1 | Healthcare | 85.83% |
| 2 | Consumer Discretionary | 2.09% |
| 3 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amicus Therapeutics
FOLD
$2.34B
| $25.1M | 15.53% | 1,775,000 -189,565 | -10% | -$2.68M |
|
|
AGTC
2
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $11.5M | 7.09% | +748,000 | New | +$11.5M |
|
|
3
Veracyte
VCYT
$2.39B
| $8.89M | 5.5% | +798,100 | New | +$8.89M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $8.13M | 5.02% | 886,000 +216,804 | +32% | +$1.99M |
|
5
Ascendis Pharma
ASND
$11.8B
| $7.46M | 4.61% | 421,851 +193,239 | +85% | +$3.42M |
|
|
BEAT
6
DELISTED
BioTelemetry, Inc.
BEAT
| $6.22M | 3.85% | 660,000 +178,931 | +37% | +$1.69M |
|
|
SPNC
7
DELISTED
Spectranetics Corp
SPNC
| $5.75M | 3.56% | +250,000 | New | +$5.75M |
|
|
NDRM
8
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $4.61M | 2.85% | 300,000 +196,833 | +191% | +$3.02M |
|
|
ALIM
9
DELISTED
Alimera Sciences, Inc.
ALIM
| $4.49M | 2.78% | 974,318 -80,491 | -8% | -$371K |
|
|
AGEN
10
Agenus
AGEN
$133M
| $3.83M | 2.37% | +443,868 | New | +$3.83M |
|
|
SRNE
11
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.74M | 2.31% | +212,402 | New | +$3.74M |
|
|
INNL
12
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $3.47M | 2.15% | 237,287 +72,828 | +44% | +$1.07M |
|
|
SIOX
13
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $3.47M | 2.14% | +170,000 | New | +$3.47M |
|
14
Build-A-Bear
BBW
$803M
| $3.2M | 1.98% | 200,000 +50,000 | +33% | +$800K |
|
|
RRM
15
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
| $3.08M | 1.91% | 410,000 +4,576 | +1% | +$34.4K |
|
|
AVID
16
DELISTED
Avid Technology Inc
AVID
| $3.07M | 1.9% | 230,000 +129,182 | +128% | +$1.72M |
|
|
17
LeMaitre Vascular
LMAT
$2.16B
| $3.02M | 1.86% | 250,000 -216,279 | -46% | -$2.61M |
|
|
CASM
18
DELISTED
CAS Medical Systems, Inc.
CASM
| $3.02M | 1.86% | 2,355,355 +195,355 | +9% | +$250K |
|
|
ALBO
19
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.97M | 1.84% | +2,886,731 | New | +$2.97M |
|
|
TLGT
20
DELISTED
Teligent, Inc
TLGT
| $2.92M | 1.8% | +462,944 | New | +$2.92M |
|
|
CYNA
21
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $2.76M | 1.71% | +169,616 | New | +$2.76M |
|
|
OXFD
22
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.74M | 1.69% | 197,680 -24,546 | -11% | -$340K |
|
23
IRIDEX
IRIX
$22.8M
| $2.58M | 1.59% | 312,450 +76,933 | +33% | +$635K |
|
|
CASC
24
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.51M | 1.55% | +670,000 | New | +$2.51M |
|
25
Collegium Pharmaceutical
COLL
$1.22B
| $2.32M | 1.43% | +130,000 | New | +$2.32M |
|